我国67家医院用药安全自我评估结果分析

Analysis of medication safety self-assessment results of 67 hospitals in China

目的初步了解我国医疗机构用药安全管理现状。方法合理用药国际网络(INRUD)中国中心组临床安全用药组和中国药理学会药源性疾病学专业委员会联合成立课题组,组织INRUD中国中心组临床安全用药组成员单位本着自愿的原则对本单位用药安全状况进行自我测评。自我测评采用《2011版ISMP医院用药安全自我评估标准(中文版)》中的调查问卷。该问卷包含10个关键元素,20个核心指标,270个测评项目。调查问卷发放时间为2018年8月17日,要求在2个月内完成问卷填写和提交。结果至规定时间共有16个省级行政区的67家医院提交了调查问卷,其中三级医院61家(91.0%),二级医院6家(9.0%)。67家参评医院用药安全自我测评平均总得分为58.9%(7.6%~90.0%)。67家医院均未对关键元素Ⅵ(药品治疗设备的采购、使用和监控维护)进行评估,其他9个关键元素的得分由高至低依次为Ⅶ(环境因素、工作流程及人员配备模式,67.6%)、Ⅳ(药品标签、包装和命名,66.2%)、Ⅸ(患者教育,65.1%)、Ⅲ(用药医嘱及其他药品信息的传递,64.8%)、Ⅷ(员工能力与教育,64.1%)、Ⅴ(药品标准化、储存和分发,58.2%)、Ⅹ(质量流程和风险管理,54.5%)、Ⅰ(患者信息,54.4%)和Ⅱ(药品信息,52.5%)。结论首次开展的全国性医疗机构用药安全自我评估问卷调查获得了16个省级行政区67家医院的用药安全相关数据,这些数据初步反映了我国医疗机构的用药安全现状。

ObjectiveTo preliminarily understand the current status of medication safety management of medical institutions in China.MethodsMedication Safety Panel in China Core Group of International Network for the Rational Use of Drugs (INRUD) and Chinese Pharmacological Society Professional Committee of Drug-induced Diseases jointly established a research group. Basing on the voluntary principle, members (medical institutions) of the group did medication safety self-assessment using the questionnaires of "2011 ISMP Medication Safety Self Assessment for Hospitals (Chinese version)", which included 10 key elements, 20 core indicators, and 270 assessment projects. The questionnaires were handed out on August 17, 2018 and needed to be completed and submitted within 2 months.ResultsAs of October 19, 2018, 67 hospitals of 16 provincial administrative regions in total had submitted their questionnaires, including 61 (91.0%) 3A hospitals and 6 (9%) 2A hospitals. The average value of total scores of medication safety self-assessment in the 67 hospitals was 58.9%(7.6%-90.0%). None of the 67 hospitals evaluated the key element Ⅵ(medication device acquisition, use, and monitoring). The scores of the other 9 key elements from high to low were 67.6%, 66.2%, 65.1%, 64.8%, 64.1%, 58.2%, 54.5%, 54.4%, and 52.5% respectively for element Ⅶ(environmental factors, workflow and staffing patterns), element Ⅳ(drug labeling, packaging and nomenclature), element Ⅸ(patient education), element Ⅲ(communication of drug orders and other drug information), element Ⅷ(staff competency and education), element Ⅴ(drug standardization, storage and distribution), element Ⅹ(quality processes and risk management), element Ⅰ(patient information), and element Ⅱ(drug information).ConclusionThe data of medication safety from 67 hospitals of 16 provincial administrative regions were obtained through the first national self-assessment questionnaire survey in medical institutions, which initially reflected the current status of medication safety in medical institutions in China.